Sivem-Irbesartan/HCT recall in Canada: impurity risk
In plain language
This recall involves Sivem-Irbesartan/HCT tablets sold in Canada. They are being recalled because they contain an impurity above acceptable limits. Stop using the product and follow the return steps in the official notice.
What to do
- Stop using the product immediately.
- Check the lot numbers if provided.
- Return the product as instructed.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Sivem-Irbesartan/HCT 150/12.5 mg Tablet
Model: DIN 02385317
Lot: JN5054, JV2163, JY7867, KT2519, KT2520
Sivem-Irbesartan/HCT 300/12.5 mg Tablet
Model: DIN 02385325
Lot: JP2979, JP2980, JU8206, JU8207
Sivem-Irbesartan/HCT 300/25 mg Tablet
Model: DIN 02385333
Lot: JX8881, JX8882, JB0216
Why this matters
Presence of impurity
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: JN5054, JV2163, JY7867, KT2519, KT2520, JP2979, JP2980, JU8206, JU8207, JX8881, JX8882, JB0216
- 3
Check the model number
Model numbers are typically on the product label or packaging.
Affected models: DIN 02385317, DIN 02385325, DIN 02385333
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Presence of impurity
What should consumers do?
Stop using the product immediately. Check the lot numbers if provided. Return the product as instructed.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Presence of impurity
When was this product recalled?
This product was recalled on May 26, 2021.
Is the Sivem-Irbesartan/HCT brand affected by this recall?
Yes, Sivem-Irbesartan/HCT products are affected by this recall. This recall involves Sivem-Irbesartan/HCT tablets sold in Canada. They are being recalled because they contain an impurity above acceptable limits. Stop using the product and follow the return steps in the official notice.